Direct Links to important GMP API Guidelines

FDA Guidance for Industry: Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA

This guidance is intended for holders of Type II active pharmaceutical ingredient (API) drug master files (DMFs) that will be referenced in an abbreviated new drug application (ANDA), or a prior approval supplement (PAS) to an ANDA

more

APIC - Sharing Drug Substance M7 information to HA and MAH: “How to do” document - Interpretation of the ICH M7 guideline and other relevant guidelines with regard to M7 data sharing

more

APIC - Data Integrity - Frequently Asked Questions (FAQ)

more

APIC - Practical risk-based guide for managing Data Integrity

more

WHO Protocol to conduct equilibrium solubility experiments for the purpose of Biopharmaceutics Classification System-based classification of active pharmaceutical ingredients for biowaiver

The objective of this document is to provide guidance on the design and conduct of equilibrium solubility studies undertaken for the purpose of active pharmaceutical ingredient (API) classification within the Biopharmaceutics Classification System (BCS) (1, 2)

more

GMP Conferences by Topics